Day: December 6, 2021

Indonesia needs to build awareness in disaster-prone areas: MPR

Semarang, Central Java People’s Consultative Assembly (MPR RI) Deputy Speaker Lestari Moerdijat has stressed that central and regional stakeholders need to be consistent in building awareness on disasters among the people living in disaster-prone areas. “Stakeholders must consistently build awareness among the people in disaster-prone areas so that they understand

Indonesia pushing immunization of vulnerable groups, children

Jakarta The government is continuing to expedite efforts to vaccinate vulnerable groups and children to limit the potential spread of the Omicron variant of COVID-19, Coordinating Minister for Economic Affairs, Airlangga Hartarto, has said. “In this case, because many children are also affected, the vaccination of children needs to be

Low chance of third COVID-19 wave happens in Indonesia: epidemiologist

The third wave has small chance of happening. Jakarta There is low chance of a third wave of COVID-19 infections occurring in Indonesia, according to an epidemiologist at Universitas Indonesia, Pandu Riono. “The third wave has small chance of happening,” Riono told ANTARA here on Monday. This is because the

Increase in Indonesia’s debt ratio relatively small: BKF

Thus, our fiscal is very controlled. Jakarta Head of the Fiscal Policy Office (BKF) of the Finance Ministry, Febrio Kacaribu, has said that the increase in Indonesia’s debt ratio amid the COVID-19 pandemic has been relatively small compared to other countries. “Our debt ratio only increased around 10 percent of

Indonesia receives additional 1.9 million doses of AstraZeneca vaccine

With the arrival of the 147th stage amounting to 1,932,000 doses of AstraZeneca vaccine, the total number of vaccine doses that Indonesia has received, both in finished and bulk form (raw materials) reaches 395,544,580 Jakarta Director-General of Information and Public Communication at the Communications and Informatics Ministry Usman Kansong has

Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12

First and only neutralizing antibody therapy for this age group SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (the